Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PierFranco Spano

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Parkinsonism & Related Disorders|July 22, 2008
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's diseaseChiara Fiorentini, Chiara Busi, Pierfranco Spano, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 20, 2008
Should we be cautious on the use of commercially available antibodies to dopamine receptors?Serena Bodei, Nicola Arrighi, PierFranco Spano, et al.
Journal of Receptor and Signal Transduction Research|August 6, 2010
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexesCristina Missale, Chiara Fiorentini, Ginetta Collo, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 21, 2014
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissuesArianna Bellucci, Chiara Fiorentini, Michela Zaltieri, et al.
Neuropeptides|March 9, 2004
Increased serum concentration of nerve growth factor in patients with microprolactinomaSandra Sigala, Antonio Martocchia, Cristina Missale, et al.
Brain Research|December 14, 2011
α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's diseaseArianna Bellucci, Laura Navarria, Michela Zaltieri, et al.
The FEBS Journal|December 18, 2008
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerabilityMarina Pizzi, Ilenia Sarnico, Annamaria Lanzillotta, et al.
The Journal of Biological Chemistry|March 21, 2003
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptorsChiara Fiorentini, Fabrizio Gardoni, PierFranco Spano, et al.
Functional Neurology|January 6, 2004
Alzheimer's disease linking neurodegeneration with neurodevelopmentMariagrazia Grilli, Giulia Ferrari Toninelli, Daniela Uberti, et al.
The European Journal of Neuroscience|May 2, 2002
Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophreniaMartina Ballmaier, Michele Zoli, Giuseppina Leo, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Parkinsonism & Related Disorders|July 22, 2008
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's diseaseChiara Fiorentini, Chiara Busi, Pierfranco Spano, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 20, 2008
Should we be cautious on the use of commercially available antibodies to dopamine receptors?Serena Bodei, Nicola Arrighi, PierFranco Spano, et al.
Journal of Receptor and Signal Transduction Research|August 6, 2010
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexesCristina Missale, Chiara Fiorentini, Ginetta Collo, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 21, 2014
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissuesArianna Bellucci, Chiara Fiorentini, Michela Zaltieri, et al.
Neuropeptides|March 9, 2004
Increased serum concentration of nerve growth factor in patients with microprolactinomaSandra Sigala, Antonio Martocchia, Cristina Missale, et al.
Brain Research|December 14, 2011
α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's diseaseArianna Bellucci, Laura Navarria, Michela Zaltieri, et al.
The FEBS Journal|December 18, 2008
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerabilityMarina Pizzi, Ilenia Sarnico, Annamaria Lanzillotta, et al.
The Journal of Biological Chemistry|March 21, 2003
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptorsChiara Fiorentini, Fabrizio Gardoni, PierFranco Spano, et al.
Functional Neurology|January 6, 2004
Alzheimer's disease linking neurodegeneration with neurodevelopmentMariagrazia Grilli, Giulia Ferrari Toninelli, Daniela Uberti, et al.
The European Journal of Neuroscience|May 2, 2002
Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophreniaMartina Ballmaier, Michele Zoli, Giuseppina Leo, et al.
Pageof 9